Asthma and chronic obstructive pulmonary disease are both common conditions with an
increasing prevalence worldwide. Inhaled therapy for these conditions has a number of …

Impressive advances in inhalation therapy for patients with asthma and chronic obstructive
pulmonary disease (COPD) have occurred in recent years. However, important gaps in care …

Different molecular subtypes of glioblastoma (GBM) have been recently identified, of which
the mesenchymal subtype is associated with worst prognoses. Here, we report that …

Background Patients with COPD may be prescribed multiple inhalers as part of their
treatment regimen, which require different inhalation techniques. Previous literature has …

Inhaled therapies are the cornerstone of treatment in asthma and chronic obstructive
pulmonary disease, and there are a multitude of devices available. There is, however, a …

Chronic obstructive pulmonary disease (COPD) is common in older people, with an
estimated prevalence of 10% in the US population aged≥ 75 years. Inhaled medications …

This review integrates pharmaceutical science with routine clinical practice to explain why
inhalation manoeuvres through a dry powder inhaler (DPI) should start with a gentle …

Background Cross-sectional observational studies suggest that between 50% and 60% of
patients misuse a dry powder inhaler, whereas studies with electronic monitors indicate that …

The patients' inhalation flow pattern is one of the significant determinants for clinical
performance of inhalation therapy. However, the development of inhalation flow meters for …

Background Chronic obstructive pulmonary disease (COPD) affects an estimated 14% of
adults in the United States between the ages of 40 and 79 years. This progressive disease is …